Cronos Company Leadership

CRON Stock  USD 2.05  0.04  1.99%   
Cronos' insiders are aggressively buying. The analysis of insiders' sentiment of trading Cronos Group stock suggests that virtually all insiders are extremely bullish at this time. Cronos employs about 356 people. The company is managed by 12 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 29.67 employees per reported executive.

Cronos' Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2023-05-30Jason Marc AdlerAcquired 37500 @ 1.74View
2023-05-25Jason Marc AdlerAcquired 100000 @ 1.8View
2023-05-19Jason Marc AdlerAcquired 100000 @ 1.89View
2022-12-14Jason Marc AdlerAcquired 94600 @ 2.83View
2022-12-08Jason Marc AdlerAcquired 162400 @ 2.86View
2022-12-06Jason Marc AdlerAcquired 37000 @ 3.03View
2022-11-28Jason Marc AdlerAcquired 22700 @ 3.03View
2022-11-22Jason Marc AdlerAcquired 49800 @ 3.04View
2022-11-17Jason Marc AdlerAcquired 81000 @ 2.94View
Monitoring Cronos' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Cronos' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Cronos' future performance. Based on our forecasts, it is anticipated that Cronos will maintain a workforce of about 630 employees by December 2024.
 
Covid

Cronos Management Team Effectiveness

The company has return on total asset (ROA) of (0.0373) % which means that it has lost $0.0373 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0529) %, meaning that it created substantial loss on money invested by shareholders. Cronos' management efficiency ratios could be used to measure how well Cronos manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to grow to -0.06. In addition to that, Return On Capital Employed is likely to drop to -0.08. At this time, Cronos' Non Current Assets Total are very stable compared to the past year. As of the 22nd of November 2024, Other Current Assets is likely to grow to about 6.5 M, while Total Assets are likely to drop about 808.6 M.
As of the 22nd of November 2024, Common Stock Shares Outstanding is likely to drop to about 233.9 M. In addition to that, Net Loss is likely to grow to about (144.3 M)

Cronos Workforce Comparison

Cronos Group is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 14,178. Cronos holds roughly 356 in number of employees claiming about 2.51% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.54) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.54.

Cronos Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cronos insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cronos' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cronos insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
2.0
4
2
 208,584 
 19,485 
2024-06-01
0.5833
7
12
 46,454 
 98,872 
2024-03-01
0.8235
28
34
 2,759,512 
 1,072,394 
2023-12-01
0.6667
4
6
 177,202 
 243,656 
2023-09-01
2.0
6
3
 328,339 
 33,915 
2023-06-01
1.9167
23
12
 634,099 
 175,062 
2023-03-01
1.0
23
23
 3,323,673 
 1,274,439 
2022-12-01
5.8889
53
9
 2,992,816 
 424,466 
2022-09-01
0.2143
3
14
 520,429 
 2,219,463 
2022-06-01
0.1818
2
11
 66,917 
 172,174 
2022-03-01
0.8667
13
15
 5,003,089 
 3,771,961 
2021-12-01
0.2857
2
7
 139,376 
 382,402 
2021-09-01
2.3333
7
3
 1,027,373 
 22,557 
2021-06-01
0.4
4
10
 52,809 
 67,779 
2021-03-01
0.6071
17
28
 12,989,165 
 13,949,989 
2020-12-01
0.2727
3
11
 5,308,130 
 7,696,027 
2020-09-01
1.4
7
5
 3,168,396 
 702,585 

Cronos Notable Stakeholders

A Cronos stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cronos often face trade-offs trying to please all of them. Cronos' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cronos' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael JDCEO PresidentProfile
Jeffrey JacobsonVice President - Business DevelopmentProfile
James IIIController VPProfile
Arye WeigensbergSenior DevelopmentProfile
Shayne LaidlawDirector StrategyProfile
Terry DoucetGeneral SecretaryProfile
Kevin GiffordVP FinProfile
James HolmChief OfficerProfile
Anna ShlimakSenior StrategyProfile
Shannon BuggySenior PeopleProfile
Carlos CortezController VPProfile
Adam WagnerSenior IsraelProfile

About Cronos Management Performance

The success or failure of an entity such as Cronos Group often depends on how effective the management is. Cronos management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cronos management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cronos management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.07)(0.06)
Return On Capital Employed(0.08)(0.08)
Return On Assets(0.06)(0.06)
Return On Equity(0.07)(0.06)

Cronos Workforce Analysis

Traditionally, organizations such as Cronos use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cronos within its industry.

Cronos Manpower Efficiency

Return on Cronos Manpower

Revenue Per Employee249.6K
Revenue Per Executive7.4M
Net Loss Per Employee199.8K
Net Loss Per Executive5.9M
Working Capital Per Employee2.5M
Working Capital Per Executive74.3M
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.144
Earnings Share
(0.12)
Revenue Per Share
0.267
Quarterly Revenue Growth
0.46
Return On Assets
(0.04)
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.